Zora Biosciences is a diagnostics discovery company. We identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods.
We use our existing mass spectrometry platforms, our extensive collaborator network for clinical studies, and in-licensing capabilities to generate biomarker candidates. Appropriate studies using well characterized and sizeable sample sets are employed for series of validation runs. Extensive patenting is sought for all discovery IP through our expert partner patent offices.
The central commercialization pathway in the United States is the licensing of Zora IP to reference laboratories that develop LDTs (Laboratory Developed Test) under CLIA regulation. Potential multi-national kit approaches for the diagnostic products are also possible.